Wanda Christ,Sebastian Kapell,Michal J. Sobkowiak,Georgios Mermelekas,Bjorn Evertsson,Helena Sork,Osama Saher,Safa Bazaz,Oskar Gustafsson,Eduardo I. Cardenas,Viviana Villa,Roberta Ricciarelli,Johan K Sandberg,Jonas Bergquist,Andrea Sturchio,Per Svenningsson,Tarja Malm,Alberto J. Espay,Maria Pernemalm,Anders Linden,Jonas Klingstrom,Samir EL Andaloussi,Kariem Ezzat

Abstract:The corona virus (SARS-CoV-2) pandemic and the resulting long-term neurological complications in patients, known as long COVID, have renewed the interest in the correlation between viral infections and neurodegenerative brain disorders. While many viruses can reach the central nervous system (CNS) causing acute or chronic infections (such as herpes simplex virus 1, HSV-1), the lack of a clear mechanistic link between viruses and protein aggregation into amyloids, a characteristic of several neurodegenerative diseases, has rendered such a connection elusive. Recently, we showed that viruses can induce aggregation of purified amyloidogenic proteins via the direct physicochemical mechanism of heterogenous nucleation (HEN). In the current study, we show that the incubation of HSV-1 and SARS-CoV-2 with human cerebrospinal fluid (CSF) leads to the amyloid aggregation of several proteins known to be involved in neurodegenerative diseases, such as: APLP1 (amyloid beta precursor like protein 1), ApoE, clusterin, α2-macroglobulin, PGK-1 (phosphoglycerate kinase 1), ceruloplasmin, nucleolin, 14-3-3, transthyretin and vitronectin. Importantly, UV-inactivation of SARS-CoV-2 does not affect its ability to induce amyloid aggregation, as amyloid formation is dependent on viral surface catalysis via HEN and not its ability to replicate. Additionally, viral amyloid induction led to a dramatic drop in the soluble protein concentration in the CSF. Our results show that viruses can physically induce amyloid aggregation of proteins in human CSF and result in soluble protein depletion, and thus providing a potential mechanism that may account for the association between persistent and latent/reactivating brain infections and neurodegenerative diseases.

SARS-CoV-2 impairs the disassembly of stress granules and promotes ALS-associated amyloid aggregation

Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid--associated pathology in APP/PS1 mouse model of Alzheimer's disease

Amyloid precursor protein facilitates SARS-CoV-2 virus entry into cells and enhances amyloid-β-associated pathology in APP/PS1 mouse model of Alzheimer’s disease

Aberrant Stress Granule Dynamics and Aggrephagy in ALS Pathogenesis

SARS-CoV-2 Spike Protein S1 Domain Accelerates α-Synuclein Phosphorylation and Aggregation in Cellular Models of Synucleinopathy

Amyloidogenic proteins in the SARS-CoV and SARS-CoV-2 proteomes

Cell invasive amyloid assemblies from SARS-CoV-2 peptides can form multiple polymorphs with varying neurotoxicity

SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication

SARS-CoV-2 and HSV-1 Induce Amyloid Aggregation in Human CSF Resulting in Drastic Soluble Protein Depletion

Neurotoxic amyloidogenic peptides in the proteome of SARS-COV2: potential implications for neurological symptoms in COVID-19

Nucleocapsid proteins from human coronaviruses possess phase separation capabilities and promote FUS pathological aggregation

SARS-CoV-2 Nsp7 Plays a Role in Cognitive Dysfunction by Impairing Synaptic Plasticity

Distinct Effects of SARS‐CoV‐2 Protein Segments on Structural Stability, Amyloidogenic Potential, and α‐Synuclein Aggregation

An amyloidogenic fragment of the SARS CoV-2 envelope protein promotes serum amyloid A misfolding and fibrillization

SARS-CoV-2 nucleocapsid protein phase separates with G3BPs to disassemble stress granules and facilitate viral production

SARS-CoV-2 NSP5 and N protein counteract the RIG-I signaling pathway by suppressing the formation of stress granules

The SARS‐CoV‐2 nucleocapsid protein suppresses innate immunity by remodeling stress granules to atypical foci

SARS-CoV-2 N protein enhances the anti-apoptotic activity of MCL-1 to promote viral replication

Low complexity domains of the nucleocapsid protein of SARS-CoV-2 form amyloid fibrils

SARS-CoV-2 Nucleocapsid Protein Antagonizes GADD34-Mediated Innate Immune Pathway through Atypical Foci